Consensus WELL Health Technologies Corp.

Equities

WELL

CA94947L1022

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 09:30:42 2025-07-10 am EDT			5-day change	1st Jan Change
4.820 ^CAD	-0.21%		+14.18%	-29.59%

Jul. 09	WELL Health Technologies Price Target Raised to $5.25 at CIBC	MT
Jul. 08	Toronto Stocks Decline; BRP Shares Rise on Manitou Asset Sale	DJ

Evolution of the Average Target: WELL Health Technologies Corp.

Evolution of the Target Price: WELL Health Technologies Corp.

Changes in Analyst Recommendations: WELL Health Technologies Corp.

3022b3dce638c093aaa719.9b7M8IeL251CjbK8eJZoKkT1jmAA2A9h_DQVXO3i17g.uYf8n9fZq-87teePSdlaTxag9FNm7Uk1tGJeEd2ahtXY0pbdxbmwsCTMig~c919826bee518934a5fe7a925b3350eb

Analysts' recommendations: WELL Health Technologies Corp.

WELL Health Technologies Price Target Raised to $5.25 at CIBC	Jul. 09	MT
WELL Health Technologies Kept at Buy Following Q4 Results; Price Target Lowered to C$9.00	Apr. 16	MT
WELL Health Price Target Lowered to $7.50 at RBC	Mar. 31	MT
Healwell AI Initiated at Outperform, $3 Price Target at Raymond James	Mar. 12	MT
WELL Health Technologies Price Target Raised to $8.50 at RBC	Jan. 07	MT
WELL Health Technologies Price Target Raised to $8.50 at TD	Dec. 17	MT
WELL Health Technologies Price Target Raised to $7 at RBC	Dec. 13	MT
WELL Health Technologies Price Target Raised to $6 at RBC	24-08-07	MT
WELL Health Maintained at Buy at Stifel GMP as it Buys 10 Clinics From Shoppers Drug Mart; Price Target Kept at C$11.00	24-04-18	MT
WELL Health Technologies Rises 3%, TD Says Shopper Drug Mart Deal Likely For "Low Price"	24-04-17	MT
WELL Health Technologies Initiated at Outperform, $5.50 Price Target at RBC	24-02-06	MT
WELL Health Technologies Maintained at Buy at Stifel GMP Following Clinic Acquisitions; Price Target Kept at C$13.50	23-05-23	MT
WELL Health Technologies Initiated at Outperform, $8.50 Price Target at Raymond James	23-04-25	MT
WELL Health Technologies Buy Rating Reiterated at Stifel GMP Following Good Q4 Results; Price Target Kept at C$13.50	23-03-22	MT
WELL Health Technologies Buy Rating Kept at Stifel GMP as Credit Facility Expanded	22-07-19	MT
WELL Health Technologies Kept at Buy at Stifel GMP Following Formation of a Canadian Clinic Unit	22-07-15	MT
Scotiabank's Take on Well Health's INLIV Acquisition	22-06-21	MT
Scotiabank Maintains Outperform, $9 TP on Well Health After Company Releases Prelim Q1 Results	22-04-26	MT
WELL HEALTH TECHNOLOGIES : Target Price Increased to $11 at TD, Analyst Sees More Acquisitions	21-06-08	MT
WELL HEALTH TECHNOLOGIES : Rises More than 5%, TD Says MyHealth Acquisition Likely To Be Viewed "Positively"	21-06-07	MT
WELL HEALTH TECHNOLOGIES : Upgraded to Buy After Intrahealth Acquisition	21-03-09	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	WELL HEALTH TECHNOLOGIES CORP.					+58.39%
	HCA HEALTHCARE, INC.					+2.83%
	CVS HEALTH CORPORATION					+19.61%
	FRESENIUS SE & CO. KGAA					+15.37%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+14.91%
	LABCORP HOLDINGS INC.					+7.72%
	QUEST DIAGNOSTICS INCORPORATED					+6.04%
	FRESENIUS MEDICAL CARE AG					+9.17%
	TENET HEALTHCARE CORPORATION					+9.08%
	MAX HEALTHCARE INSTITUTE LIMITED					-4.01%
	Average					+13.91%
	Weighted average by Cap.					+10.38%